Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium

Abstract Background Immune checkpoint inhibitors (ICIs) have contributed to a significant advancement in the treatment of cancer, leading to improved clinical outcomes in many individuals with advanced disease. Both preclinical and clinical investigations have shown that ICIs are associated with ath...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Bingxin Gong, Yusheng Guo, Yi Li, Jing Wang, Guofeng Zhou, Yong-hao Chen, Tong Nie, Ming Yang, Kun Luo, Chuansheng Zheng, Feng Pan, Bo Liang, Lian Yang
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2024-01-01
Σειρά:	BMC Medicine
Θέματα:	Atherosclerosis Immunotherapy Cardiovascular disease Coronary artery calcium Imaging
Διαθέσιμο Online:	https://doi.org/10.1186/s12916-024-03261-x
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!